Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma
about
Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamicsBeyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphomaCentral nervous system prophylaxis in diffuse large B-cell lymphoma.Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report.Progress in central nervous system lymphomas.Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoLeptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trialsPharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphomaNew approaches in primary central nervous system lymphoma.How I treat CNS lymphomas.Treatment of newly diagnosed B-cell origin primary CNS lymphoma with systemic R-IDARAM chemotherapy and intrathecal immunochemotherapyRecent advances in treatment of primary central nervous system lymphoma.Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).Complement activation and intraventricular rituximab distribution in recurrent central nervous system lymphoma.Diagnosis and treatment of primary CNS lymphoma.Objective cerebrospinal fluid response to intraventricular rituximab in indolent CNS lymphomaPhosphodiesterase type 5 inhibitor Tadalafil increases Rituximab treatment efficacy in a mouse brain lymphoma model.The Challenge of Primary Central Nervous System Lymphoma.Diagnosis and Management of Leukemic and Lymphomatous Meningitis.Primary central nervous system lymphoma: essential points in diagnosis and management.Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study.Safety and efficacy of intrathecal rituximab in children with B cell lymphoid CD20+ malignancies: An international retrospective study.Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma.Advances in the treatment of newly diagnosed primary central nervous system lymphomas.High-dose chemotherapy and autologous stem cell transplantation for secondary central nervous system lymphoma: many are called, but few are chosen.Biology of CNS lymphoma and the potential of novel agents.Effect of rituximab on primary central nervous system lymphoma: a meta-analysis.Primary CNS Lymphoma.
P2860
Q26849243-B85E5D15-D189-43BD-86E9-9089AB798AE8Q27013785-6B69EE3C-5EF2-4042-BC28-7CF993F7F6F1Q30251550-C66BF7E2-7F2B-4150-B7DB-B299E09EF740Q30409639-E2E9EEB3-2EEC-40F5-8B25-6083EF41F2E0Q33934406-1EA0067D-ACE3-4E47-A04F-7DE3AAD1402EQ34943963-8B7C3147-636F-46F5-9511-F7BBD86FC7FEQ35175149-E0D5E3F8-B440-43C6-A225-61BF9072B710Q36600202-442C9CF9-122D-4068-80BC-ADF53206560EQ36907849-EF3DFFDE-A1A3-418D-8E18-ACA07A2BA3E7Q37088471-5B5D1A56-54E4-4E43-B0AE-5B5314E68927Q37215118-86DC523B-65CF-457C-938A-3FC9D5BEB145Q37295494-F5803778-695D-4C66-A3CE-2C998986198BQ37345440-9CB9891C-6504-47DF-B3AF-5EDDEA074831Q37618814-1B99FEF5-CA3F-40DB-A215-73E4BFC9ED17Q37620923-19E90F0B-29EE-43D1-8089-6CC5C566F0D6Q38106613-14EFF38E-0295-4FCB-B9BC-FC22E56E450DQ38779978-1E4F22C5-00FD-4134-B063-10A4D59CF6C8Q38927027-64A31156-639E-455E-BAC6-0CB2D9FFB306Q39020652-196D969A-3B75-408B-B2A5-787BF4C00855Q39126738-6F7B6350-004A-450D-91C6-14013CF0F166Q39185721-2E3938C2-0754-4445-B56F-70083BF9F8D8Q39484584-E7D35535-0C50-430A-B180-6312D3C6013FQ40912836-EB1D9B3C-BF3E-49CC-AA2C-3714CFA0EC0EQ41472355-E88FCB8C-D6C7-44E1-AD32-0D9340EF5803Q42377771-9DD78684-D2A0-410A-A7B5-3E78B6D36B56Q43181386-A0112B22-4D56-4084-8242-7798CBE7456BQ45985951-0BCDB565-A8B2-43C2-BC6B-8E0D99FB4B80Q47813195-D8F2AAD9-0F02-48CB-8FFE-F755DBB8EC54Q51841565-EA408186-9A04-4310-BD29-C6F9E8EC88B0
P2860
Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Multicenter phase 1 trial of i ...... rapy in recurrent CNS lymphoma
@ast
Multicenter phase 1 trial of i ...... rapy in recurrent CNS lymphoma
@en
type
label
Multicenter phase 1 trial of i ...... rapy in recurrent CNS lymphoma
@ast
Multicenter phase 1 trial of i ...... rapy in recurrent CNS lymphoma
@en
prefLabel
Multicenter phase 1 trial of i ...... rapy in recurrent CNS lymphoma
@ast
Multicenter phase 1 trial of i ...... rapy in recurrent CNS lymphoma
@en
P2093
P2860
P1433
P1476
Multicenter phase 1 trial of i ...... rapy in recurrent CNS lymphoma
@en
P2093
Cigall Kadoch
Clifford Lowell
Elizabeth Gerstner
Glenna Auerback
Hendrikus Krouwer
James Hwang
James L Rubenstein
Jan Drappatz
Lingjing Chen
P2860
P304
P356
10.1182/BLOOD-2012-07-440974
P407
P577
2012-11-29T00:00:00Z